Completed Equality Screenings - Quarter 3 - October 2014 - December 2014
Date published:
In fulfilling the commitments within its Equality Scheme the Department equality screens policies to assess the impact and determine if a full Equality Impact Assessment (EQIA) is required.
Documents
- Firefighters and New Firefighters Pension Schemes – Amendment Orders 2014
- The Firefighters’ Compensation Scheme (Amendment) Order (NI) 2014
- NICE Clinical Guideline CG30 - Long-acting reversible contraception (update)
- NICE Clinical Guideline CG81 - The addendum to NICE clinical guideline 81 has added recommendations on exercise in people with or at risk of breast-cancer-related lymphoedema to section 1.5 of the NICE guideline
- NICE Clinical Guideline CG183 - Drug allergy: diagnosis and management of drug allergy in adults, children and young people
- NICE Clinical Guideline CG184 - Dyspepsia and gastro-oesophageal reflux disease: Investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both
- NICE Clinical Guideline CG185 - Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care - updates and replaces NICE clinical guideline 38 (published July 2006)
- NICE Clinical Guideline CG186 - Multiple sclerosis: management of multiple sclerosis in primary and secondary care
- NICE Clinical Guideline CG187 - Acute heart failure: diagnosing and managing acute heart failure in adults
- NICE Clinical Guidelines CG188 - Gallstone Disease: Diagnosis and management of cholelithiasis, cholecystitis and choledocholithiasis
- NICE Technology Appraisal TA320 - Dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis
- NICE Technology Appraisal TA 321 - Dabrafenib for treating unresectable, advanced or metastatic BRAFV600 mutation-positive melanoma
- NICE Technology Appraisal TA323 - Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer-treatment induced anaemia (including review of TA142)
- NICE Technology Appraisal TA324 - Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block, (part review of Technology Appraisal 88)
- NICE Technology Appraisal TA325 - Nalmefene for reducing alcohol consumption in people with alcohol dependence
- NICE Technology Appraisal TA - Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality
- Secondary Uses of Service User Information
- Standards for Supported Lodgings for Young Adults (aged 16-21) in Northern Ireland